Should Diagnostics & Research Stock ENDRA Life Sciences Inc (NDRA) Be in Your Portfolio Wednesday?

ENDRA Life Sciences Inc (NDRA) is around the bottom of the Diagnostics & Research industry according to InvestorsObserver. NDRA received an overall rating of 1, which means that it scores higher than 1 percent of all stocks. ENDRA Life Sciences Inc also achieved a score of 1 in the Diagnostics & Research industry, putting it above 1 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 113 out of the 148 industries.

NDRA has an Overall Score of 1. Find out what this means to you and get the rest of the rankings on NDRA!

See Full NDRA Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 1 means the stock is more attractive than 1 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With ENDRA Life Sciences Inc Stock Today?

ENDRA Life Sciences Inc (NDRA) stock is up 5.52% while the S&P 500 is lower by -0.38% as of 10:06 AM on Wednesday, Oct 18. NDRA has risen $0.06 from the previous closing price of $1.03 on volume of 6,275 shares. Over the past year the S&P 500 has risen 17.11% while NDRA is lower by -83.07%. NDRA lost -$3.48 per share the over the last 12 months. Click Here to get the full Stock Report for ENDRA Life Sciences Inc stock.